Related Experiment Video
Updated: Jul 6, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Clozapine-related tachycardia: A conundrum to identify and treat
Dermot Brennan1, Sweta Lal1,2, Frans Hugo1
1Armadale Health Service, East Metropolitan Health Service, Armadale, WA, Australia.
Insights
Clozapine frequently causes tachycardia in patients with psychotic disorders. While beta-blockers can lower heart rates, they may not fully mitigate cardiovascular risks associated with clozapine treatment.
Area of Science:
- Psychiatry
- Cardiology
- Pharmacology
Background:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- Clozapine is associated with significant cardiovascular side effects, including tachycardia.
- The impact of beta-blockers on clozapine-induced tachycardia requires further investigation.
Purpose of the Study:
- To determine the incidence and persistence of clozapine-induced tachycardia.
- To assess the effect of beta-blockers on heart rate in patients treated with clozapine.
- To analyze cardiovascular risks in a large cohort of patients with psychotic disorders.
Main Methods:
- Retrospective audit of medical files for 101 patients receiving clozapine.
- Analysis of monthly resting heart rate measurements.
- Comparison of heart rates in patients treated with and without beta-blockers.
Main Results:
- 51% of patients met criteria for clozapine-induced tachycardia.
- Heart rates remained stable over the study period.
- Beta-blockers demonstrated a small but statistically significant reduction in heart rates.
Conclusions:
- Clozapine-induced tachycardia is common and its cardiovascular risks are often underestimated.
- Beta-blockers may help manage elevated heart rates but might not fully eliminate cardiac risks.
- Further research is needed to optimize cardiovascular safety in clozapine-treated patients.
Objective:
This study examined the rates and persistence of clozapine-induced tachycardia and heart-rate differences in patients treated with β-blockers in the largest sample of patients with a psychotic disorder to date.
Method:
An audit of medical files for 101 patients who attended a clozapine community clinic and analysis of monthly measurements of resting heart rates.
Results:
51% met the clinical criteria for tachycardia. Heart rates were stable over time. β-blockers were associated with small but significant reductions in heart rates.
Conclusion:
The cardiovascular risks of clozapine are often overlooked. β-blockers are useful in lowering heart rates but they may be insufficient to reduce cardiac risk.
Related Concept Videos
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Psychosis: Goals of Pharmacotherapy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Mechanism of Cardiac Arrhythmias

